BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

University of California, Davis (UCD) and Beijing Genomics Institute (BGI) Complete Master Agreement to Create BGI@UCDavis Genome Facility


2/21/2012 9:16:03 AM

LOS ANGELES -- The University of California, Davis, and China-based BGI, the world's largest genomics organization, based in China, signed a master agreement today (Feb. 17) sealing a partnership that will change the landscape of genomic sciences in California and the Western states. The BGI@UC Davis alliance will foster critical breakthroughs in the areas of food security, human, animal and environmental health.

The master agreement was signed today by UC Davis Provost Ralph G. Hexter and Hao Zhang, director of BGI@UC Davis,at a morning ceremony in Los Angeles, with high-ranking dignitaries from China and the United States attending.

"Today marks an exciting new chapter in the collaboration between UC Davis, with our strengths in biology, medicine, food and the environment, and BGI, the world's premier genomics organization," said UC Davis Chancellor Linda P. B. Katehi. "The discoveries that flow from this partnership will have a worldwide impact."

Under the agreement, UC Davis faculty and students will gain access to the capabilities and expertise of one of the world's premier genomics and bioinformatics institutes, while BGI researchers will be able to access the university's diverse resources and expertise in education and research, especially in biology, human and veterinary medicine, agriculture, and the environment.

Jian Wang, president of BGI stated, "We look forward to a highly productive relationship with UC Davis, one of the top research universities in the U.S., especially in the areas of agricultural, environmental and biological research. Given UC Davis' expertise in these areas, coupled with BGI's expertise in genome sequencing and bioinformatics, we expect this partnership and the establishment of BGI@UC Davis Joint Genome Center to lead to significant scientific breakthroughs."

In June of 2011, Katehi and Wang signed the initial agreement to establish the BGI@UCDavis partnership during a meeting in Shenzhen, one of China's Special Economic Zones.

This was followed by a second agreement signed in October 2011 that established an interim BGI facility for immediate use at the UC Davis School of Medicine in Sacramento and initiated planning for a permanent BGI@UC Davis facility. That signing ceremony, held in Sacramento for this second agreement was attended by both Qin Xu, the mayor of Shenzhen, and Kevin Johnson, the mayor of Sacramento.

Under the October 2011 agreement, BGI has moved three state-of-the-art DNA sequencing machines into the interim facility on the UC Davis Sacramento campus. When complete, the facility will accommodate ten such machines, dramatically increasing the DNA sequencing capacity readily available to campus researchers.

The partnership between BGI and UC Davis will provide new opportunities for researchers at both institutions, said Harris Lewin, vice chancellor for research at UC Davis. It will enable them to tackle bigger and more complex problems and assemble teams that can compete for bigger grants. It will also act as a catalyst to bring new companies and businesses to Sacramento, Lewin said.

The BGI@UCDavis facility will partner with the existing UC Davis Genome Center, located in the Genome and Biomedical Sciences Facility on the UC Davis campus in the further development of genomics at UC Davis. Since it opened in 2004, the Genome Center has recruited more than 15 faculty, building expertise in genomics and bioinformatics and developed five technology cores that serve faculty from campus and elsewhere. The new BGI@UCDavis facility will dramatically increase the capacity for sequencing at UC Davis.

Genomics is a discipline of biology concerning the study of the genome, or all the genes of an organism. The field includes intensive efforts to determine the genomes of plants, animals, microbes and other living things, as a way to better understand how they grow, develop and function. Since the first human genome was completed in 2001, the genomes of many other plants and animals have been sequenced, including lab animals and plants, crops such as rice, and disease-causing microbes.

About BGI

BGI was founded in Beijing, China in 1999, with the mission of being a premier scientific partner to the global research community. The goal of BGI is to make leading-edge genomic science highly accessible through its investment in infrastructure that leverages the best available technology, economies of scale and expert bioinformatics resources. BGI, and its affiliates, BGI Americas, based in Cambridge, MA and BGI Europe, based in Copenhagen, Denmark, have established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, supporting a variety of disease, agricultural, environmental and related applications. BGI has established a proven track record of excellence, delivering results with high efficiency and accuracy for innovative, high profile research, which has generated more than 170 publications in top-tier journals such as Nature and Science. These accomplishment include sequencing one percent of the human genome for the International Human Genome Project, contributing 10 percent to the international Human HapMap Project, carrying out research to combat SARS and deadly German E. coli, playing a key role in the Sino-British Chicken Genome Project, and completing the sequence of the rice genome, the silkworm genome, the first Asian diploid genome, the potato genome and, most recently, 1,000 genomes and human gut metagenome. For more information about BGI, please visit www.genomics.cn and www.bgiamericas.com.

About UC Davis

For more than 100 years, UC Davis has engaged in teaching, research and public service that matter to California and transform the world. Located close to the state capital, UC Davis has more than 32,000 students, more than 2,500 faculty and more than 21,000 staff, an annual research budget that exceeds $684 million, a comprehensive health system and 13 specialized research centers. The university offers interdisciplinary graduate study and more than 100 undergraduate majors in four colleges - Agricultural and Environmental Sciences, Biological Sciences, Engineering, and Letters and Science. It also houses six professional schools - Education, Law, Management, Medicine, Veterinary Medicine and the Betty Irene Moore School of Nursing.

Contacts:

UC Davis

Andy Fell

UC Davis News Service

530-752-4533

ahfell@ucdavis.edu

BGI

Joyce Peng, Ph.D.

Marketing Director

BGI Americas Corporation

626-222-5584

joyce.peng@bgiamericas.com

www.bgiamericas.com

Bicheng Yang

Public Communication Officer

BGI

+86-755-82639701

yangbicheng@genomics.cn

www.genomics.cn

Scott A. Rieger

Access IR PR

619-994-5994



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES